Genoptix Financial Statements
Genoptix Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
Genoptix Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 59.3 | 24.0 | 5.2 |
| Gross Profit ($ mil.) | 35.2 | 10.9 | 0.0 |
| Operating Income ($ mil.) | 13.0 | (3.9) | (9.1) |
| Total Net Income ($ mil.) | 13.4 | (3.8) | (9.2) |
| Diluted EPS (Net Income) | 0.78 | (33.74) | (111.33) |
Genoptix Stock Quote & Chart
| 11/21/08 16:00:12 EST •
NASDAQ •
29.89
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Genoptix Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 10.24 | 0.90 | 1.56 |
| Price/Earnings Ratio | 30.62 | 18.06 | 15.82 |
| Price/Book Ratio | 6.70 | 2.13 | 1.52 |
| Price/Cash Flow Ratio | 46.35 | 8.15 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Genoptix Financial Ratios
Genoptix Competitive Intelligence
| Bio-Reference Labs | Genzyme | LabCorp | |
|---|---|---|---|
| Annual Sales ($ mil.) | 250.4 | 3,813.5 | 4,068.2 |
| Employees | 1,648 | 10,000 | 26,000 |
| Market Cap ($ mil.) | 371.6 | 22,314.3 | 8,037.0 |
Competitive Landscape





